Mereo BioPharma Group (MREO) News Today $2.86 -0.04 (-1.38%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Needham & Company LLC Reiterates Buy Rating for Mereo BioPharma Group (NASDAQ:MREO)January 15, 2025 | americanbankingnews.comOptimism in Mereo Biopharma: Strong Phase II Results and Strategic Advancements Fuel Buy RatingJanuary 15, 2025 | markets.businessinsider.comMereo Biopharma’s Strategic Progress and Promising Pipeline Drive Buy RatingJanuary 14, 2025 | markets.businessinsider.comBTIG Sticks to Its Buy Rating for Mereo Biopharma Group Plc (MREO)January 14, 2025 | markets.businessinsider.comMereo BioPharma Group (NASDAQ:MREO) Sets New 52-Week Low - Here's WhyMereo BioPharma Group (NASDAQ:MREO) Sets New 52-Week Low - Here's WhyJanuary 14, 2025 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Shares Gap Down - What's Next?Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Down - What's Next?January 13, 2025 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Receives "Buy" Rating from Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $7.00 price objective on shares of Mereo BioPharma Group in a report on Monday.January 13, 2025 | marketbeat.comMereo BioPharma Group plc: Mereo BioPharma Provides Update on Lead Clinical ProgramsJanuary 13, 2025 | finanznachrichten.deMereo BioPharma Provides Update on Lead Clinical ProgramsJanuary 12, 2025 | globenewswire.comMereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | globenewswire.comMereo BioPharma Group plc (NASDAQ:MREO) Receives Average Recommendation of "Buy" from BrokeragesShares of Mereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) have received an average rating of "Buy" from the seven brokerages that are currently covering the company, MarketBeat reports. Four analysts have rated the stock with a buy recommendation and three have issued a strong buy recommDecember 31, 2024 | marketbeat.comWhy Mereo BioPharma (MREO) Is One of the Best Biotech Penny Stocks to Invest in Now?December 30, 2024 | msn.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Down 2.6% - Here's WhyMereo BioPharma Group (NASDAQ:MREO) Stock Price Down 2.6% - Time to Sell?December 26, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Upgraded by Lifesci Capital to Strong-Buy RatingLifesci Capital upgraded shares of Mereo BioPharma Group to a "strong-buy" rating in a report on Monday.December 25, 2024 | marketbeat.comLifeSci Capital Initiates Coverage of Mereo BioPharma Group plc - Depositary Receipt () (MREO) with Outperform RecommendationDecember 25, 2024 | msn.comMereo BioPharma Group (NASDAQ:MREO) Shares Gap Up - Time to Buy?Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up - What's Next?December 24, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Now Covered by Lifesci CapitalLifesci Capital started coverage on shares of Mereo BioPharma Group in a research note on Tuesday. They set an "outperform" rating and a $10.00 price target on the stock.December 24, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Hits New 1-Year Low - Should You Sell?Mereo BioPharma Group (NASDAQ:MREO) Sets New 12-Month Low - Here's What HappenedDecember 20, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Sees Strong Trading Volume - What's Next?Mereo BioPharma Group (NASDAQ:MREO) Sees Strong Trading Volume - What's Next?December 18, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Down 4.5% - Time to Sell?Mereo BioPharma Group (NASDAQ:MREO) Shares Down 4.5% - What's Next?December 16, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Raised to Strong-Buy at Cantor FitzgeraldCantor Fitzgerald upgraded Mereo BioPharma Group to a "strong-buy" rating in a report on Sunday.December 10, 2024 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Shares Purchased by Frazier Life Sciences Management L.P.Frazier Life Sciences Management L.P. boosted its holdings in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 15.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,097,779 shares of thDecember 10, 2024 | marketbeat.comMereo Biopharma Group Plc: Strong Buy Rating Due to Promising Pipeline and Strategic PartnershipsDecember 6, 2024 | markets.businessinsider.comJefferies Initiates Coverage of Mereo BioPharma Group plc - Depositary Receipt () (MREO) with Buy RecommendationDecember 6, 2024 | msn.comMereo BioPharma Group (NASDAQ:MREO) Shares Gap Up - Still a Buy?Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up - Still a Buy?December 6, 2024 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Given Average Recommendation of "Buy" by BrokeragesShares of Mereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) have been given a consensus rating of "Buy" by the five analysts that are currently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy recommendation and one has issued aDecember 6, 2024 | marketbeat.comJefferies Financial Group Begins Coverage on Mereo BioPharma Group (NASDAQ:MREO)Jefferies Financial Group began coverage on Mereo BioPharma Group in a research report on Friday. They set a "buy" rating and a $7.00 target price on the stock.December 6, 2024 | marketbeat.comJanus Henderson Group PLC Purchases 4,464,984 Shares of Mereo BioPharma Group plc (NASDAQ:MREO)Janus Henderson Group PLC lifted its position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 56.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,345,866 shares of the company's stock after purchasing an adDecember 6, 2024 | marketbeat.comAcuta Capital Partners LLC Has $5.18 Million Position in Mereo BioPharma Group plc (NASDAQ:MREO)Acuta Capital Partners LLC increased its stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 86.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,260,700 shares of the company's stock aNovember 28, 2024 | marketbeat.comMereo BioPharma: Setrusumab Chugs Along With Possible Inflection PointsNovember 26, 2024 | seekingalpha.comWhat is Leerink Partnrs' Forecast for MREO FY2024 Earnings?Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Stock analysts at Leerink Partnrs issued their FY2024 EPS estimates for Mereo BioPharma Group in a research report issued on Monday, November 18th. Leerink Partnrs analyst J. Schwartz anticipates that the company will post earnings of $0.06November 21, 2024 | marketbeat.comWhat is Leerink Partnrs' Forecast for MREO Q1 Earnings?Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Mereo BioPharma Group in a report released on Monday, November 18th. Leerink Partnrs analyst J. Schwartz expects that the company will post earnings per shareNovember 20, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Reaches New 52-Week Low - Time to Sell?Mereo BioPharma Group (NASDAQ:MREO) Hits New 52-Week Low - Here's What HappenedNovember 15, 2024 | marketbeat.comMereo Biopharma Group Plc: Positive Developments and Strong Growth Potential Justify Buy RatingNovember 14, 2024 | markets.businessinsider.comPositive Outlook for Mereo Biopharma Group Plc Amidst Promising Therapeutic Developments and Strong Financial PositionNovember 14, 2024 | markets.businessinsider.comMereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare ConferenceNovember 14, 2024 | globenewswire.comMereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 12, 2024 | globenewswire.comMereo BioPharma Group (NASDAQ:MREO) Shares Down 4.4% - Time to Sell?Mereo BioPharma Group (NASDAQ:MREO) Stock Price Down 4.4% - Here's WhyNovember 4, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Down 6.4% - Here's WhyMereo BioPharma Group (NASDAQ:MREO) Shares Down 6.4% - Time to Sell?October 23, 2024 | marketbeat.comIs Mereo BioPharma Group (MREO) the Hottest Penny Stock to Invest in According to Hedge Funds?October 16, 2024 | msn.comMillennium Management LLC Buys 1,022,570 Shares of Mereo BioPharma Group plc (NASDAQ:MREO)Millennium Management LLC grew its stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 46.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,201,705 shares of the company's stock aOctober 8, 2024 | marketbeat.comMarshall Wace LLP Takes Position in Mereo BioPharma Group plc (NASDAQ:MREO)Marshall Wace LLP bought a new position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,144,051 shares of the company's stock, valued at approximately $October 3, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Given "Overweight" Rating at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $7.00 price objective on shares of Mereo BioPharma Group in a research report on Tuesday.October 1, 2024 | marketbeat.comPerceptive Advisors LLC Invests $4.51 Million in Mereo BioPharma Group plc (NASDAQ:MREO)Perceptive Advisors LLC bought a new stake in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,253,250 shares of the company's stock, valued at approximatSeptember 30, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Makes New Investment in Mereo BioPharma Group plc (NASDAQ:MREO)Frazier Life Sciences Management L.P. bought a new position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 4,401,371 shares of the company's stock, valued at approximSeptember 29, 2024 | marketbeat.comBlue Owl Capital Holdings LP Takes $3.23 Million Position in Mereo BioPharma Group plc (NASDAQ:MREO)Blue Owl Capital Holdings LP acquired a new stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 897,809 shares of the company's stock, valued at approSeptember 28, 2024 | marketbeat.comDeerfield Management Company L.P. Series C Invests $24.16 Million in Mereo BioPharma Group plc (NASDAQ:MREO)Deerfield Management Company L.P. Series C acquired a new stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,710,September 26, 2024 | marketbeat.comIntegral Health Asset Management LLC Has $6.39 Million Stock Holdings in Mereo BioPharma Group plc (NASDAQ:MREO)Integral Health Asset Management LLC increased its position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 86.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,775,000 shares of the company'September 23, 2024 | marketbeat.comRubric Capital Management LP Grows Position in Mereo BioPharma Group plc (NASDAQ:MREO)Rubric Capital Management LP grew its stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 12.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,307,347 shares of the company's stock after purchasing an additiSeptember 21, 2024 | marketbeat.comMereo BioPharma Group plc (MREO): A Bull Case TheorySeptember 18, 2024 | msn.com Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address MREO Media Mentions By Week MREO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MREO News Sentiment▼0.350.44▲Average Medical News Sentiment MREO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MREO Articles This Week▼52▲MREO Articles Average Week Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AKRO News Today BLTE News Today IRON News Today AMPH News Today WVE News Today APGE News Today INDV News Today GLPG News Today GPCR News Today ARQT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MREO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
